EU CHMP confirms negative opinion on marketing authorisation application of intravitreal pegcetacoplan from Apellis
The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response
EURETINA 2024: Genotype-phenotype correlations in a cohort of patients with genetically determined retinitis pigmentosa
Stefano Mercuri, MD, speaks about his team's August Deutman award-winning research on retinitis pigmentosa and Rho gene mutations
EURETINA 2024: The global VOYAGER study provides real-world, scalable findings
Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD
EURETINA 2024: Bahram Bodaghi, MD, PHD, FEBO, says the Congress "starts with innovation"
Prof Bodaghi praises the ingenuity at this year's EURETINA Innovation Spotlight (EIS)
EURETINA 2024: The future of medical retina is "brilliant" for clinicians and patients
Enrico Borrelli, MD, FEBO, speaks about opportunities in the retina space
EURETINA 2024: Aleksandra Rachitskaya, MD, FASRS, and the Vit-Buckle Society come to Barcelona
Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD
EURETINA 2024: Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
The general secretary of the European Society of Retina Specialists (EURETINA) says the future of AI is here
EURETINA 2024: Alexandra Miere, MD, PhD, sees oculomics rising to the top
Editorial advisory board member Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care
EURETINA 2024: Factors predictive of macular oedema development in patients with silicone oil tamponade
Additional previous surgeries and the duration of the SO tamponade had little or no impact
EURETINA 2024: Tyrosine kinase inhibitors and safety data for patients with non proliferative diabetic retinopathy
Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial
EURETINA 2024: Boris Stanzel, MD, shares research on fluid monitoring and fixation clouds
New research and EURETINA highlights from the director of the "underdog" eye clinic
EURETINA 2024: Kyoko Ohno-Matsui, MD, PhD, shares a keynote on cutting-edge technologies for pathologic myopia
How retinal imaging can provide clinicians a deeper understanding of myopia
EURETINA 2024: Keynote speaker Yousif Subhi, MD, PhD, on keeping patients in focus
Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"
EMA announces positive opinion for SB15 (OPUVIZ, Samsung Bioepis and Biogen)
The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission
EURETINA 2024: Subretinal drusenoid deposit load and correlation with an increased risk of stroke
Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk
EURETINA 2024: Andrea Govetto, MD, PhD, says it takes teamwork to understand macular oedema
We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA
EURETINA 2024: Unraveling the genetic spectrum of combined retinal dystrophy and hearing impairment
Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies
EURETINA 2024: Ricardo Leitão Guerra, MD, MSc, FICO, speaks about multimodal imaging
Why having a set process for diagnostic imaging is crucial to patient outcomes
EURETINA 2024: Subretinal gene therapy improves function and structure in patients with Bothnia Dystrophy
Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.
EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination
A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies
EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure
The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients
EURETINA 2024: Efficacy results and patient preference findings from the Pagoda trial
Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences
Study examines navigation performance in glaucoma with virtual-reality-based assessment of path integration
Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma
See what our Editorial Advisory Board members are bringing to EURETINA
Spotlight on the retina specialists who make up the Eye Care Network advisory boards
Industry preview: Ophthalmic companies bring updates, new research findings to EURETINA
Businesses in the retina care space tease new technologies and cutting-edge therapeutics
Celebrate World Retina Day at the 2024 EURETINA Congress
As part of the Barcelona meeting, retina specialists can recognise the awareness day early
24th EURETINA Congress: The art of retina on stage in Barcelona
Focus on collaboration, career development and innovation
Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award
The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field
Trinity team’s gene therapy offers promising glaucoma and AMD treatment
Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells
ESCRS 2024: Approaching a paradigm shift in cell therapy for corneal oedema and endothelial dysfunction
Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress
